ClinicalTrials.gov
public full text
Public Domain
Expanded Access to Convalescent Plasma for Treatment of COVID-19
This expanded access program will provide access to investigational convalescent plasma for patients at Hackensack University Medical Center infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP)#1046506
- Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)#828255
- Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions#903862
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients#861950
- Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)#911054
Record · ID 992706
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive